ApprovalTrail

Approval · Notice of Compliance 17199 · 2015

VISKEN: Notice of Compliance 17199

Issued August 14, 2015

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
17199
Date
August 14, 2015
Company
Tribute Pharmaceuticals Canada IncMississauga, Ontario, Canada
Product type
Prescription Pharmaceutical
Submission
New Drug Submission (NDS)
Submission class
Admin
Reason
Transfer of drug identification numbers

Products in this notice

BrandDINStatus today
VISKEN00417270Dormant
VISKEN00443174Dormant
VISKEN00417289Cancelled Post Market

Medicinal ingredients